Skip to main content
. Author manuscript; available in PMC: 2014 Apr 1.
Published in final edited form as: Cancer. 2012 Dec 20;119(7):1321–1329. doi: 10.1002/cncr.27910

Figure 1.

Figure 1

Expression of FXR in esophageal cancer cells and tissue specimens. (a) Tissue samples from 59 esophageal adenocarcinoma patients were immunostained for FXR and hybridized in situ for RAR-β2 expression. The association of the expression of FXR with RAR-β2 was determined by the McNemar test. (b) Expression of FXR mRNA and protein in esophageal squamous cell carcinoma TE-3 and Te-12 cells and adenocarcinoma SKGT-4 and SKGT-5 cells using semi-quantitative RT-PCR and Western blot, respectively.